Luis M. Barrera-Martinez
Dr. Ismael Cosío Villegas
Mexico City, DIF, Mexico
Mexico City, DIF, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Mutation profile in liquid biopsy tested by next generation sequencing in Mexican patients with non-small cell lung carcinoma and its impact on survival.
Journal: Journal of thoracic disease
Published: June 30, 2023
Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas.
Journal: Journal of cancer research and clinical oncology
Published: May 31, 2022
Survival prognostic factors in unresectable/advanced primary thoracic sarcomas.
Journal: Journal of thoracic disease
Published: April 09, 2022
Prognostic factors for progression-free and overall survival in malignant pleural mesothelioma.
Journal: Thoracic cancer
Published: October 06, 2020
Brigatinib in ALK-positive non-small cell lung cancer: real-world data in the Latin American population (Bri-world extend CLICaP).
Journal: Future oncology (London, England)
Published: September 28, 2020
A comparative study of immunotherapy as second-line treatment and beyond in patients with advanced non-small-cell lung carcinoma.
Journal: Lung cancer management
Published: September 21, 2020
Human skin biomarkers relationship to response to treatment with tyrosine kinase inhibitors in advanced EGFR-mutated lung adenocarcinoma.
Journal: Thoracic cancer
Published: June 23, 2020
Real-World Evidence: Multicenter Efficacy and Toxicity Analysis of Nintedanib With Docetaxel as Second-Line Treatment in Mexican Patients With Advanced Lung Adenocarcinoma.
Journal: JCO global oncology
Published: March 21, 2020
Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma.
Journal: Journal of thoracic disease
Published: June 11, 2019
National Clinical Practice Guidelines for the management of non-small cell lung cancer in early, locally advanced and metastatic stages. Extended version.
Journal: Salud publica de Mexico
Published: July 25, 2018
First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial.
Journal: British journal of cancer
Published: February 23, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026